Risk factors and outcome of COVID-19 in patients with hematological malignancies
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk factors and outcome of COVID-19 in patients with hematological malignancies
Authors
Keywords
-
Journal
Experimental Hematology & Oncology
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-25
DOI
10.1186/s40164-020-00177-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
- (2020) Jin-jin Zhang et al. ALLERGY
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
- (2020) Wenhua Liang et al. LANCET ONCOLOGY
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
- (2020) Lirong Zou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City
- (2020) H. Miyashita et al. ANNALS OF ONCOLOGY
- COVID-19 outcomes in patients with hematologic disease
- (2020) Florent Malard et al. BONE MARROW TRANSPLANTATION
- Survival study of hospitalised patients with concurrent COVID‐19 and haematological malignancies
- (2020) Fernando Martín‐Moro et al. BRITISH JOURNAL OF HAEMATOLOGY
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Early Short Course Corticosteroids in Hospitalized Patients with COVID-19
- (2020) Raef Fadel et al. CLINICAL INFECTIOUS DISEASES
- Predictors for Severe COVID-19 Infection
- (2020) Ashish Bhargava et al. CLINICAL INFECTIOUS DISEASES
- Clinical features of 1487 COVID-19 patients with outpatient management in the Greater Paris: the COVID-call study
- (2020) Frédéric Lapostolle et al. Internal and Emergency Medicine
- Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
- (2020) Jing Yang et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)
- (2020) Hiroshi Nishiura et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
- (2020) Eli S. Rosenberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal
- (2020) Hasan K. Siddiqi et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis
- (2020) Zhenwei Yang et al. JOURNAL OF INFECTION
- Decreased B cells on admission was associated with prolonged viral RNA shedding from respiratory tract in Coronavirus Disease 2019: a case control study
- (2020) Shaorui Hao et al. JOURNAL OF INFECTIOUS DISEASES
- Asymptomatic cases with SARS‐CoV‐2 infection
- (2020) Yishan Wang et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical features and treatment of COVID-19 patients in northeast Chongqing
- (2020) Suxin Wan et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
- (2020) Nicole M Kuderer et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility
- (2020) Melissa M. Arons et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak
- (2020) Mengyuan Dai et al. Cancer Discovery
- Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
- (2020) Vikas Mehta et al. Cancer Discovery
- Plasma CRP level is positively associated with the severity of COVID-19
- (2020) Wei Chen et al. Annals of Clinical Microbiology and Antimicrobials
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward
- (2020) Bo Wang et al. Journal of Hematology & Oncology
- Can steroids reverse the severe COVID‐19 induced “cytokine storm”?
- (2020) Lykourgos Kolilekas et al. JOURNAL OF MEDICAL VIROLOGY
- COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus
- (2020) Lydia Scarfò et al. LEUKEMIA
- Effects of Corticosteroid Treatment for Non-Severe COVID-19 Pneumonia
- (2020) Mingli Yuan et al. SHOCK
- The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell transplantation: a prospective epidemiological survey
- (2019) José Luis Piñana et al. BONE MARROW TRANSPLANTATION
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
- (2016) Shaji Kumar et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation